AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

IRTC · NASDAQ · Medical - Devices

iRhythm (IRTC)

Provider of Zio patch-based ECG monitoring, analytics, and physician-ready cardiac reports.

$121.95

Pre-market−0.67 (−0.55%)

At close$122.62(+0.22%)

Watchlist

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	125	133	132	148	148	164	159	187	193	209	199	224
Cost of revenue	42	45	44	45	46	49	49	54	56	61	58	61
Gross profit	82	87	88	103	101	115	109	133	137	148	141	163
	110	127	126	126	152	119	141	147	141	139	153	166
Research & development	16	15	17	20	48	19	22	21	21	21	21	20
Selling, general & administrative	94	100	109	107	103	100	120	126	120	118	136	132
Other expenses	0	11	0	0	1	0	0	0	0	0	−4	14
Operating income	−28	−39	−38	−23	−50	−4	−32	−15	−4	9	−12	−3
	1	1	−7	3	4	3	2	0	−1	−3	−2	2
Interest income	2	2	3	6	6	6	5	5	6	5	5	5
Interest expense	1	1	3	3	3	3	3	3	3	3	3	3
Other non-operating income	−2	−2	5	−6	−8	−6	−5	−3	−2	−1	−2	−5
Income before tax	−27	−38	−46	−20	−46	−1	−30	−14	−5	6	−13	0
Income tax expense	0	0	0	0	0	0	1	0	0	0	1	0
Net income from continuing operations	−27	−39	−46	−20	−46	−1	−31	−14	−5	6	−14	0
Net income	−27	−39	−46	−20	−46	−1	−31	−14	−5	6	−14	0
EPS, basic	−$0.89	−$1.26	−$1.47	−$0.65	−$1.48	−$0.04	−$0.97	−$0.44	−$0.16	$0.17	−$0.43	−$0.01
EPS, diluted	−$0.89	−$1.26	−$1.47	−$0.65	−$1.48	−$0.04	−$0.97	−$0.44	−$0.16	$0.17	−$0.43	−$0.01
Weighted average shares, basic	31	31	31	31	31	31	32	32	32	32	33	33
Weighted average shares, diluted	31	31	31	31	31	31	32	32	32	33	33	33
EBITDA	−20	−31	−36	−10	−36	9	−20	−5	5	16	−4	3
Depreciation & amortization	6	6	6	6	6	7	7	7	7	7	7	0
EBIT	−26	−38	−43	−17	−43	2	−27	−11	−2	9	−10	3